Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination

Human Reproduction

Volumn 12, Issue 9, 1997, Pages 1886-1889

  Mercan, Ramazan ^a   Mayer, Jacob F ^a   Walker, Denise ^a   Jones, Stella ^a   Oehninger, Sergio ^a   Toner, James P ^a   Muasher, Suheil J ^a  

^a The Jones Institute for Reproductive Medicine   (United States)

Author keywords

HMG; Oocyte quality; Pregnancy rates; Pure FSH

Indexed keywords

FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OOCYTE MATURATION; PREGNANCY RATE; RETROSPECTIVE STUDY;

EID: 0030733886     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.9.1886     Document Type: Article

References (34)

1. Anderson, R.E., Cragun, J.M., Chang, R. et al. (1989) A pharmacodynamic comparison of human urinary follicle stimulating hormone and human menopausal gonadotrophin in normal women and polycystic ovary syndrome. Fertil. Steril., 52, 216-220.
2. Balasch, J., Francisco, F, Creus, M. et al. (1996) Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Hum. Reprod., 11, 2400-2404.
3. Bergh, C., Olsson, J-H., Selleskog, U. and Hillensjo, T. (1993) Steroid production in cultured thecal cells obtained from human ovarian follicles. Hum. Reprod., 8, 519-524.
4. Chappel, S.C. and Howles, C. (1991) Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum. Reprod., 6, 1206-1212.
5. Couzinet, B., Lestrat, N., Brailly, S. et al. (1988) Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotrophin deficiency. J. Clin. Endocrinol. Metab., 66, 553-556.
6. Daya, S. (1995) Follicle-stimulating hormone versus human menopausal gonadotrophin for in vitro fertilization: results of a meta-analysis. Horm. Res., 43, 224-229.
7. Daya, S., Gunby, J., Hughes, E.G. et al. (1995) Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization. Hum. Reprod., 10, 1392-1396.
8. Devroey, P., Tjandraprawira, K., Mannaerts, B. et al. (1995) A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normagen and Metrodin in infertile female patients undergoing in-vitro fertilization. Hum. Reprod., 10, 332-337.
9. Edelstein, M.C., Brzyski, R.G., Jones, G.S. et al. (1990) Equivalency of human menopausal gonadotrophin and follicle-stimulating hormone stimulation after gonadotrophin-releasing hormone suppression. Fertil. Steril., 53, 103-106.
10. Flamigni, C., Vemuroli, S. and Paradisi, R. (1985) Use of human urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome. J. Reprod. Med., 30, 184-190.
11. Fleming R., Chung, C.C., Yates R.W.S. and Coutts J.R.T. (1996) Purified urinary follicle stimulating hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum. Reprod., 11, 1854-1858.
12. Fried, G., Harlin, J., Csemiczky, G. and Wramsby, H. (1996) Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG. Hum. Reprod., 11, 474-477.
13. Hillier, S.G. (1990) Ovarian manipulation with pure gonadotrophins. J. Endocrinol., 127, 1-6.
14. Homburg, R., Armar, N.A., Eshel, A. et al. (1988) Influence of serum luteinizing hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br. Med. J., 297, 1024-1026.
15. Howles, C., MacNamee, M.C. and Edwards, R.G. (1987) Follicular development and early luteal function of conception and nonconceptional cycles after human in vitro fertilization: endocrine correlates. Hum. Reprod., 2, 17-21.
16. Howles, C.M., Loumaye, E., Giroud, D. and Luyet, G. (1994) Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study. Hum. Reprod., 9, 424-430.
17. Hull, M.R.G., Armatage, R.J. and McDermott, A. (1994) Use of folliclestimulating hormone alone (urofollitropin) to stimulate ovaries for assisted conception after pituitary desensitization. Fertil. Steril., 62, 997-1003.
18. Jacobs, H.S., Porter, R., Eshel, A. and Craft, I. (1987) In Vickery, B.H. and Nestor, I.J. (eds), LHRH and its Analogues; Contraception and Therapeutic Application II MTP Press, Lancaster, pp. 303-319.
19. Imthurn, B., Macas, E., Roselli, M. and Keller, P.J. (1996) Nuclear maturity and oocyte morphology with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin. Hum. Reprod., 11, 2387-2391.
20. Kamrava, M.M., Seibel, M.M., Berger, M.J. et al. (1982) Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic lowdose follicle-stimulating hormone. Fertil. Steril., 37, 520-523.
21. Lavy, G., Pellicer, A., Diamond, M.P. and DeCherney, A.H. (1988) Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotrophin versus pure human follicle stimulating hormone: a randomized prospective study. Fertil. Steril., 50, 74-78.
22. McNatty, K.P., Smith, D.M., Makris, A. et al. (1979) The microenvironment of the human antral follicle: interrelationship among the steroid levels in antral fluid, the population of granulosa cells and the status of the oocyte in vivo and m vitro. J. Clin. Endocrinol, Metab., 49, 851-860.
23. Polan, M.L., Daniele, A., Russel, J.B. and DeCherney, A.H. (1986) Ovulation induction with human menopausal gonadotrophin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels with discernible differences in granulosa-luteal cell function. J. Clin. Endocrinol. Metab., 63, 1284-1291.
24. Regan, L., Owen, E.J. and Jacobs, H.S. (1990) Hypersecretion of luteinizing hormone, infertility and miscarriage. Lancet, 336, 1141-1144.
25. Sccocia, B., Blumenthal, P., Wagner, C. et al. (1987) Comparison of urinary follicle stimulating hormone and human menopausal gonadotrophins for ovarian stimulation in an in vitro fertilization program. Fertil. Steril., 48, 446-449.
26. Shaw, R.W., Ndukwe, G., Imoedemhe, D.A. et al. (1985) Twin pregnancy after pituitary desensitization with LHRH agonist and pure FSH. Lancet, 11, 506.
27. Shoham, Z., Balen, A., Patel, A. and Jacobs, H.S. (1991) Results of ovulation induction using human menopausal gonadotrophin or purified follicle stimulating hormone in hypogonadotrophic hypogonadism patients. Fertil. Steril., 59, 1153-1161.
28. Söderström-Anttila V., Tuija F. and Hovatta O. (1996) A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme. Hum. Reprod., 11, 1864-1870.
29. Stanger, J. and Yovich, J.J. (1985) Reduced in vitro fertilization of human oocyte from patients with raised basal luteinizing hormone levels during the follicular phase. Br. J. Obstet. Gynaecol., 92, 385-393.
30. Tanbo, T., Dale, P.O., Ejekshus, E. et al. (1990) Stimulation with human menopausal gonadotrophin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. Fertil. Steril., 53, 798-803.
31. Tomlinson, M.J., Amissah-Arthur, J.B., Thompson, K.A. et al. (1996) Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success. Hum. Reprod., 11, 1892-1896.
32. Venturoli, S., Paradisi, R., Raffaella, F. et al. (1984) Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotrophin treatment in polycystic ovary. Obstet. Gynecol., 63, 6-11.
33. Westergaard L.G., Erb K., Laursen S. et al. (1996) The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in downregulated normogonadotrophic women. Hum. Reprod., 11, 1209-1213.
34. Wikland, M., Nilsson, L., Bergh, C. and Hamberger, L. (1995) Results from in vitro fertilization and imracytoplasmic sperm injection with purified gonadotrophins (Metrodin-HP). Horm. Res., 43, 238-240.